SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MIKE DUBIS who wrote (764)8/11/1998 5:55:00 PM
From: VLAD  Read Replies (1) of 1016
 
MIKE,

I have followed many small cap stocks that have crashed big time never to have recovered. Where this stock trades in the short term is anyones guess. Its not like we are talking about a disk drive maker that is losing $4.00-$6.00/share and can not make its loan payments.
The company has indeed made mistakes and is now paying dearly for them but I do honestly feel that the product will have a significant role in the ED market. With a strong domestic partner and new international markets, all this company has to be concerned with is to mass produce the product as cheaply as possible. As I said many times before on the long thread, they bit off more than they could chew and should have not tried to do it all alone from the get go. Mike, my only regret is not waiting longer to jump in and buy stock at these levels. I believe that those who do will be rewarded 3 to 6 months out. I still do not think that the analyst's target price of $20.00+/share is very doable looking out 6 to 12 months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext